RSS-Feed abonnieren
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1016/j.ijep.2014.03.001
Epilepsy in inborn errors of metabolism: two cases with unusual presentation
Verantwortlicher Herausgeber dieser Rubrik:
Corresponding author
Publikationsverlauf
Received: 10. September 2013
Accepted: 21. März 2014
Publikationsdatum:
04. Mai 2018 (online)
Abstract
Inherited metabolic disorders are a rare cause of epilepsy in children. We describe a case of Glutaric aciduria type 1 presenting with West syndrome and a case of intermittent Maple syrup urine disease presenting with epileptic encephalopathy. Early diagnosis and institution of appropriate therapy may be life saving and may improve the long term neurodevelopmental outcome in children with inherited metabolic disorders.
# 1
Introduction
Inherited metabolic disorders are a rare cause of epilepsy.[1] However, in many metabolic disorders, seizures are the predominant symptom especially in newborns and infants e.g. pyridoxine dependent seizures, biotinidase deficiency and glucose transporter defect. It is most important to look for those inborn errors of metabolism which are treatable with supplementation of vitamins and cofactors or special diets. We report two unusual cases of inherited metabolic disorders with associated epilepsy.
# 2
Case 1
A 10-month-old male infant presented with developmental delay and jerky movements of the head and limbs since 6 months of age. He was the second child of non-consanguineous parentage. The antenatal and perinatal periods were uneventful. He achieved social smile at 3 months and partial neck holding at 5 months. Since 6 months of age, parents noticed jerky movements with flexion of the head and upper limbs, suggestive of flexor spasms. These movements would occur in clusters whenever the child woke up from sleep. The parents did not seek any treatment for these movements. The parents also noticed progressive stiffness of both the limbs and intermitted twisting postures of the hands and feet since 8 months of age. His vision and hearing were normal. There were no other seizure types. At the time of presentation, he had partial neck holding, was recognizing his mother and cooing. He had not started holding objects yet. His elder brother had died at 4 years of age due to pneumonia. He had been developmentally normal.
Examination revealed an alert infant with no facial dysmorphism or neurocutaneous features. His head circumference was 48 cm (>2 SD). His weight and length were age appropriate. The general physical and systemic examination revealed no abnormalities. Neurological examination revealed increased tone, brisk muscle stretch reflexes and bilateral extensor plantar responses. He also had hands and feet dyskinesias. The fundus examination was normal.
Investigations revealed normal hemogram, liver and kidney function tests. The EEG showed modified hypsarrhythmia ([Fig. 1]). The MRI of the brain showed hyperintense signal changes involving bilateral basal ganglia with fronto–temporal atrophy ([Fig. 2]). The tandem mass spectrometry of blood showed elevated glutarylcarnitine & low carnitine levels. His Urine gas chromatography and mass spectrometry showed highly elevated glutaric acid levels (>10,000 mmol/mol of creatinine).
![](https://www.thieme-connect.de/media/10.1055-s-00037682/201401/thumbnails/10-1016-j-ijep-2014-03-001_gr1.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
![](https://www.thieme-connect.de/media/10.1055-s-00037682/201401/thumbnails/10-1016-j-ijep-2014-03-001_gr2.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
A diagnosis of glutaric aciduria type 1 with West syndrome was made. The patient was started on riboflavin, carnitine and oral prednisolone (2 mg/kg/day). His spasms subsided within 5 days of starting steroids, which were tapered off after 2 weeks. The repeat EEG showed resolution of hypsarrhythmia. The patient was initiated with physical rehabilitation. Six months after the diagnosis, he has shown some improvement – he has achieved neck holding and has started reaching out for objects.
# 3
Case 2
An 18-month-old boy presented with history of jerky movements of the head along with regression of developmental milestones for the last 25 days. The patient was apparently well 25 days back when he developed fever and cough, which lasted for three days. On the third day of illness, the parents noticed jerky movements of the head with head flexion. These movements occurred multiple times in a day. There was no history of up-rolling of eyeballs or limb movements. The patient gradually lost the ability to walk, sit and talk over the next two weeks. He also stopped recognizing his parents. He also became drowsy and lethargic.
He had a similar episode at 13 months of age. During that episode, he had developed fever, cough and fast breathing. Then he developed jerky head movements and regression of milestones. He had been admitted in a private nursing home, where he was diagnosed to have pneumonia. He recovered completely and had regained his milestones within 7 days. He was the first child of non-consanguineous parentage. The antenatal and perinatal periods were uneventful. His developmental milestones were age appropriate prior to this illness. The family history was not significant.
On examination the child was lethargic but responsive. The anthropometry and vital parameters were normal. There was no facial dysmorphism. The general physical and systemic examination was normal. Neurological examination showed infrequent head myoclonic jerks, mild central hypotonia, normal muscle stretch reflexes and bilateral extensor plantar responses. There were no meningeal signs.
The MRI of the brain was normal. The EEG showed chaotic background with high voltage activity with intermixed spikes arising from bilateral leads ([Fig. 3]). There were also generalized polyspike wave discharges with electrodecrement. The blood ammonia, lactate, arterial blood gas analysis were normal and there was no urinary ketosis. The blood tandem mass spectrometry showed increased levels of leucine, isoleucine and valine. The urine gas chromatography mass spectrometry showed urine ketosis, and elevation of 3-hydroxy–butyrate and dicarboxylic aciduria. The findings were suggestive of maple syrup urine disease.
![](https://www.thieme-connect.de/media/10.1055-s-00037682/201401/thumbnails/10-1016-j-ijep-2014-03-001_gr3.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
Parents were advised a low protein diet. The child also received thiamine, sodium valproate and oral prednisolone. His myoclonic jerks subsided within 3 days. He became more alert and started recognizing his parents by the time of discharge. At 3 months follow up, he has started sitting and vocalizing bisyllables. A repeat EEG obtained 3 months later was normal.
# 4
Discussion
We report describes two cases with neurometabolic disorder presenting with seizures. The inborn errors of metabolism are infrequent cause of epilepsy but their early recognition and appropriate management is pivotal.
[Table 1] describes the metabolic disorders causing epilepsy. The underlying mechanisms may vary according to the metabolic disorder and includes deficiency of a vitamin or a cofactor, cerebral energy deficiency, chemical or physical disruption of neurotransmission, direct toxicity of the accumulating storage material or intermediates, associated hyperammonemia or hypoglycemia or electrolyte disturbances.[1]
Glutaric aciduria (GA) type 1 is caused by deficiency of glutaryl CoA dehydrogenase deficiency resulting in accumulation of glutarate, 3-hydroxyglutarate and glutaconate. Seizures are rarely seen in GA type 1 and usually occur during episodes of acute encephalopathy.[2] [3] Rather majority of the paroxysmal movements, which may be misdiagnosed as seizures, appear to be dystonic episodes.[4] The accumulating glutarate has recognized excitotoxic effects via N-methyl-d-aspartate (NMDA) receptor[5] and may thus be epileptogenic.
West syndrome has never been reported with GA type 1 previously although it has been rarely reported with other organic acidemias like propionic academia,[6] [7] methylmalonic academia,[8] and d-glyceric aciduria.[9] Thus, the case 1 further expands the phenotypic spectrum of GA type 1.
Maple syrup urine disease (MSUD) is caused by mitochondrial branched chain α-ketoacid dehydrogenase complex deficiency resulting in accumulation of branched chain amino acids and α-ketoacids. Five forms of MSUD have been described: classic, intermediate, intermittent, thiamine responsive and dihydrolipoyl dehydrogenase deficiency.
Case 2 had intermittent MSUD presenting with episodic encephalopathy, seizures and neuroregression with recovery. The patients with intermittent MSUD can have intractable seizures during an acute episode and the acute episodic deterioration can be fatal. However, with early diagnosis and treatment, the patients can have normal or near normal neurodevelopment. Seizures have also been described in other forms of MSUD.[10] The neurotoxicity is predominantly mediated by leucine and its transamination product 2-ketoisocaproate.[11]
Thus, inborn errors of metabolism should always be excluded in a child with unexplained seizures, especially if they are refractory to treatment. [Table 2] shows the clinical cues that may help the neurologist to suspect an inborn error of metabolism in a child with epilepsy. This report describes the first case of GA type 1 presenting with West syndrome and a child with intermittent MSUD presenting with metabolic and epileptic encephalopathy.
Associated global developmental delay Associated movement disorder – creatine deficiency, organic acidemia Worsening of seizures before meals – GLUT1 deficiency Vomiting – urea cycle disorders Abnormal urine odor – maple syrup urine disease, phenylketonuria Accelerated growth (macrosomia, tall stature) – GABA transaminase deficiency Facial dysmorphism – Zellweger syndrome Hair and skin abnormalities – Menkes disease, biotinidase deficiency Albinism – phenylketonuria Dislocated lens – sulphite oxidase deficiency Inverted nipples, abnormal fat pads – congenital disorders of glycosylation Organomegaly, coarse facies – storage disorders Multi-system involvement – mitochondrial disorders, congenital disorders of glycosylation, peroxisomal disorders |
#
Conflicts of interest
All authors have none to declare.
#
#
Die Autoren geben an, dass kein Interessenkonflikt besteht.
-
References
- 1 Rahman S, Footitt EJ, Varadkar S, Clayton PT. Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol 55 2013; 23-36
- 2 Kyllerman M, Skjeldal OH, Lundberg M. et al. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord 9 1994; 22-30
- 3 McClelland VM, Bakalinova DB, Hendriksz C, Singh RP. Glutaric aciduria type 1 presenting with epilepsy. Dev Med Child Neurol 51 2009; 235-239
- 4 Cerisola A, Campistol J, Pérez-Dueñas B. et al. Seizures versus dystonia in encephalopathic crisis of glutaric aciduria type I. Pediatr Neurol 40 2009; 426-431
- 5 De Mello CF, Kölker S, Ahlemeyer B. et al. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 916 2001; 70-75
- 6 Aldamiz-Echevarría Azuar L, Prats Viñas JM, Sanjurjo Crespo P, Prieto Perera JA, Labayru Echeverría MT. Infantile spasms as the first manifestation of propionic acidemia. An Pediatría Barc Spain 63 2005; 548-550
- 7 Harris DJ, Thompson RM, Wolf B, Yang BI. Propionyl coenzyme A carboxylase deficiency presenting as non-ketotic hyperglycinaemia. J Med Genet 18 1981; 156-157
- 8 Guevara-Campos J, González-de-Guevara L, Medina-Atopo M. Methylmalonic aciduria associated with myoclonic convulsions, psychomotor retardation and hypsarrhythmia. Rev Neurol 36 2003; 735-737
- 9 Topcu M, Saatci I, Haliloglu G, Kesimer M, Coskun T. D-glyceric aciduria in a six-month-old boy presenting with West syndrome and autistic behaviour. Neuropediatrics 33 2002; 47-50
- 10 Lee W-T. Disorders of amino acid metabolism associated with epilepsy. Brain Dev 33 2011; 745-752
- 11 Zinnanti WJ, Lazovic J, Griffin K. et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain J Neurol 132 2009; 903-918
- 12 Aneja S, Jain P. Refractory epilepsy in children. Indian J Pediatr. 2014 in press
*
Corresponding author
-
References
- 1 Rahman S, Footitt EJ, Varadkar S, Clayton PT. Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol 55 2013; 23-36
- 2 Kyllerman M, Skjeldal OH, Lundberg M. et al. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord 9 1994; 22-30
- 3 McClelland VM, Bakalinova DB, Hendriksz C, Singh RP. Glutaric aciduria type 1 presenting with epilepsy. Dev Med Child Neurol 51 2009; 235-239
- 4 Cerisola A, Campistol J, Pérez-Dueñas B. et al. Seizures versus dystonia in encephalopathic crisis of glutaric aciduria type I. Pediatr Neurol 40 2009; 426-431
- 5 De Mello CF, Kölker S, Ahlemeyer B. et al. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 916 2001; 70-75
- 6 Aldamiz-Echevarría Azuar L, Prats Viñas JM, Sanjurjo Crespo P, Prieto Perera JA, Labayru Echeverría MT. Infantile spasms as the first manifestation of propionic acidemia. An Pediatría Barc Spain 63 2005; 548-550
- 7 Harris DJ, Thompson RM, Wolf B, Yang BI. Propionyl coenzyme A carboxylase deficiency presenting as non-ketotic hyperglycinaemia. J Med Genet 18 1981; 156-157
- 8 Guevara-Campos J, González-de-Guevara L, Medina-Atopo M. Methylmalonic aciduria associated with myoclonic convulsions, psychomotor retardation and hypsarrhythmia. Rev Neurol 36 2003; 735-737
- 9 Topcu M, Saatci I, Haliloglu G, Kesimer M, Coskun T. D-glyceric aciduria in a six-month-old boy presenting with West syndrome and autistic behaviour. Neuropediatrics 33 2002; 47-50
- 10 Lee W-T. Disorders of amino acid metabolism associated with epilepsy. Brain Dev 33 2011; 745-752
- 11 Zinnanti WJ, Lazovic J, Griffin K. et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain J Neurol 132 2009; 903-918
- 12 Aneja S, Jain P. Refractory epilepsy in children. Indian J Pediatr. 2014 in press
![](https://www.thieme-connect.de/media/10.1055-s-00037682/201401/thumbnails/10-1016-j-ijep-2014-03-001_gr1.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
![](https://www.thieme-connect.de/media/10.1055-s-00037682/201401/thumbnails/10-1016-j-ijep-2014-03-001_gr2.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
![](https://www.thieme-connect.de/media/10.1055-s-00037682/201401/thumbnails/10-1016-j-ijep-2014-03-001_gr3.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)